| P50 | author | Chao-Min Wang | Q55763107 |
| P2093 | author name string | Chang-Hung Chou | |
| | Ching-Lin Shyu | |
| | Hsiao-Ting Chen | |
| | Yun-Lian Jhan | |
| | Zong-Yen Wu | |
| P2860 | cites work | Recent advances in understanding the antibacterial properties of flavonoids | Q28236221 |
| | Salvipisone and aethiopinone from Salvia sclarea hairy roots modulate staphylococcal antibiotic resistance and express anti-biofilm activity | Q33291622 |
| | Plant products as antimicrobial agents | Q33749123 |
| | Bacillus cereus, a volatile human pathogen | Q33825596 |
| | Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. | Q34245820 |
| | EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. | Q54022193 |
| | Synergy, antagonism, and what the chequerboard puts between them | Q73521098 |
| | Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride | Q74612705 |
| | Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus | Q79621700 |
| | A cage-monoterpene indole alkaloid from Alstonia scholaris | Q80515261 |
| | Modulation of antibiotic resistance in bacterial pathogens by oleanolic acid and ursolic acid | Q83461831 |
| | Synergy research: approaching a new generation of phytopharmaceuticals | Q34943025 |
| | Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. | Q35044119 |
| | The role of pentacyclic triterpenoids in the allelopathic effects of Alstonia scholaris | Q35081962 |
| | Structure Elucidation of Procyanidins Isolated from Rhododendron formosanum and Their Anti-Oxidative and Anti-Bacterial Activities. | Q35694027 |
| | MRSA: the first half century | Q37947249 |
| | Review of the phytochemical, pharmacological and toxicological properties of Alstonia Scholaris Linn. R. Br (Saptaparna). | Q37997979 |
| | Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology | Q38184246 |
| | Bioguided isolation of pentacyclic triterpenes from the leaves of Alstonia scholaris (Linn.) R. Br. growing in Egypt | Q38986140 |
| | Ethanolic extracts of Tinospora cordifolia and Alstonia scholaris show antimicrobial activity towards clinical isolates of methicillin-resistant and carbapenemase-producing bacteria | Q39002550 |
| | Chemical constituents of Rhododendron formosanum show pronounced growth inhibitory effect on non-small-cell lung carcinoma cells. | Q39032385 |
| | Mechanism of action of β-lactam antibiotics at the molecular level | Q39712020 |
| | Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. | Q39913411 |
| | Evaluation of anticancer activity of the alkaloid fraction of Alstonia scholaris (Sapthaparna) in vitro and in vivo | Q40323634 |
| | Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia | Q40406917 |
| | Symptoms of food-borne diseases and gastroenteritis in Kyushu, Japan | Q40490554 |
| | Epidemiologic profiling: evaluating foodborne outbreaks for which no pathogen was isolated by routine laboratory testing: United States, 1982-9. | Q40589382 |
| | Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities | Q43104174 |
| | Pharmacological evaluation of Alstonia scholaris: anti-inflammatory and analgesic effects | Q43134904 |
| | Oleanolic acid and ursolic acid affect peptidoglycan metabolism in Listeria monocytogenes | Q43247326 |
| | Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. | Q43778136 |
| | Synergistic interaction of eugenol with antibiotics against Gram negative bacteria. | Q45961502 |
| | Alstonic acids A and B, unusual 2,3-secofernane triterpenoids from Alstonia scholaris | Q46053549 |
| | Antimicrobial activity of 6-oxophenolic triterpenoids. Mode of action against Bacillus subtilis | Q46459598 |
| | The protective effect of Alstonia scholaris R. Br. on hepatotoxin-induced acute liver damage | Q47185948 |
| | Preliminary evaluation of extracts of Alstonia scholaris bark for in vivo antimalarial activity in mice | Q47342719 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alstonia scholaris | Q135307 |
| P304 | page(s) | 139 | |
| P577 | publication date | 2016-01-25 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Antibacterial and Synergistic Activity of Pentacyclic Triterpenoids Isolated from Alstonia scholaris | |
| P478 | volume | 21 | |